Bipartisanship hasn’t exactly been the watchword in Washington over the past month as the new Trump administration grapples with stalled nominations, court battles over its travel ban, and investigations of campaign contacts with Russia.
But deeply divided politicians may still find... Read more »
Anyone who has ever visited an emergency room knows it can be a crowded, chaotic place. Electronic health records (EHR) technology—software that puts a patient’s charts and health information online so doctors can access it, ostensibly leading to better, more efficient... Read more »
News may be coming out of Washington, DC, at a breakneck pace, but concrete plans regarding the future of the nation’s healthcare system, the FDA, and the pharmaceutical industry have been much slower to materialize. The consternation about President Donald Trump’s... Read more »
The final numbers on 2016 fintech funding deals are in from New York-based research firm and investment database CB Insights, and venture capitalists seem to be cooling on the industry.
According to a report released today, financial technology companies around the... Read more »
Another Alzheimer’s drug has failed a major test. Merck (NYSE: MRK) reported late Tuesday that its pill verubecestat was not helping people with significant Alzheimer’s symptoms. The drug maker announced that it halted its EPOCH study early because an oversight group... Read more »
Here’s a look at innovation news from across Indiana:
—Three Indiana University students won the top spots at a recent demo day competition hosted by B-Start, the Bloomington Economic Development Corporation‘s accelerator program. Zachary Burr snagged first place ($2,500) for... Read more »
The Senate confirmed Tom Price as Secretary of the U.S. Department of Health and Human Services early Friday morning by a 52-47 vote that, as expected, fell largely on party lines.
Price is an orthopedic surgeon by training who has been a... Read more »
The biotech community pushed back against President Donald Trump’s order to block travelers and refugees this week, and not much later, a federal court did, too. Patient advocates have scored big wins with recent approvals of rare disease treatments, but they’re... Read more »
In the biomedical world, perhaps the biggest question looming over President Donald Trump’s upcoming pick for Food and Drug Administration commissioner is how drastically that person will help roll back FDA regulations.
Trump said at last week’s meeting in Washington D.C.,... Read more »
The Trump administration’s travel ban will remain on a temporary hold under an order issued today by a federal appeals court in San Francisco, which held that the government had failed to make its case for lifting a stay won through... Read more »
Since Xconomy’s founding nearly a decade ago, we have grown from a single bureau in Boston to having editors covering 11 innovation clusters around the United States. And over this time, we have cultivated a reputation for outstanding news coverage and... Read more »
Susan Marshall, founder and CEO of digital marketing startup Torchlite, has been working in the technology sector for about 25 years. Her experience is mostly in product development and marketing, and she’s worked for some of the most innovative companies... Read more »
When disease decimated Ireland’s potatoes in 1845, farmers were at a loss to explain what caused their staple crop to rot in the fields. The blight continued in successive growing seasons and by 1851, more than one million deaths were attributed... Read more »